<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 對(duì)照品 > 中檢所對(duì)照品 >
    Lonafarnib-d9
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):L469447
    產(chǎn)品名稱(chēng):Lonafarnib-d9
    產(chǎn)品CAS:
    規(guī)格含量:5mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): L469447
    名稱(chēng): Lonafarnib-d9
    別名: 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide-d9; Sarasar-d9; Sch 66336-d9;
    參考CAS號(hào): 193275-84-2 unlabelled
    分子式: C??H??D?Br?ClN?O?
    分子量: 647.88
    種類(lèi): Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: Lonafarnib-d9 is the isotope laballed analog of Lonafarnib. Lonafarnib is an orally bioavailable tricyclic inhibitor of farnesyl protein transferase. It inhibits Rheb farnesylation and mTOR signaling and enhances taxane and tamoxifen antitumor activity. Studies show that it induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      韩国无码成人 电影在线观看 | 美女被鬼压床脱内衣内裤视频 | 欧美成人在线第一页 | 久久福利国产 | 无码人妻一区二区三一区免费n狂飙 |